JP2005507880A5 - - Google Patents

Download PDF

Info

Publication number
JP2005507880A5
JP2005507880A5 JP2003528088A JP2003528088A JP2005507880A5 JP 2005507880 A5 JP2005507880 A5 JP 2005507880A5 JP 2003528088 A JP2003528088 A JP 2003528088A JP 2003528088 A JP2003528088 A JP 2003528088A JP 2005507880 A5 JP2005507880 A5 JP 2005507880A5
Authority
JP
Japan
Prior art keywords
compound
chemical formula
diluent
medicament
additive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003528088A
Other languages
English (en)
Japanese (ja)
Other versions
JP4540986B2 (ja
JP2005507880A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029365 external-priority patent/WO2003024183A2/en
Publication of JP2005507880A publication Critical patent/JP2005507880A/ja
Publication of JP2005507880A5 publication Critical patent/JP2005507880A5/ja
Application granted granted Critical
Publication of JP4540986B2 publication Critical patent/JP4540986B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003528088A 2001-09-14 2002-09-16 ワートマニン類似体およびそれらを用いる方法 Expired - Fee Related JP4540986B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32213901P 2001-09-14 2001-09-14
US32214301P 2001-09-14 2001-09-14
PCT/US2002/029365 WO2003024183A2 (en) 2001-09-14 2002-09-16 Wortmannin analogs and methods of using same

Publications (3)

Publication Number Publication Date
JP2005507880A JP2005507880A (ja) 2005-03-24
JP2005507880A5 true JP2005507880A5 (enExample) 2006-01-05
JP4540986B2 JP4540986B2 (ja) 2010-09-08

Family

ID=26983283

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528088A Expired - Fee Related JP4540986B2 (ja) 2001-09-14 2002-09-16 ワートマニン類似体およびそれらを用いる方法

Country Status (8)

Country Link
EP (1) EP1435941B8 (enExample)
JP (1) JP4540986B2 (enExample)
AT (1) ATE334671T1 (enExample)
AU (1) AU2002330029B2 (enExample)
CA (1) CA2458318C (enExample)
DE (1) DE60213633T2 (enExample)
MX (1) MXPA04002445A (enExample)
WO (1) WO2003024183A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081475B2 (en) 2001-09-14 2006-07-25 Prolx Pharmaceuticals Corp. Wortmannin analogs and methods of using same
DE10219545A1 (de) * 2002-04-26 2003-11-06 Lang Florian Regulation der Apoptose
US7230139B2 (en) 2002-12-05 2007-06-12 Gemin X Biotechnologies Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
MXPA05011248A (es) * 2003-04-23 2005-12-14 Wyeth Corp Derivados de wortmanina solubles en agua.
DE102004043463A1 (de) * 2004-06-09 2006-02-09 Heinz Voigt Mittel zur Krebsbekämpfung unter Verwendung von Schimmelpilzextrakten
EP1901738A4 (en) * 2004-07-09 2009-11-11 Prolx Pharmaceuticals Inc WORDMANNIN ANALOGA AND METHOD FOR USE IN COMBINATION WITH CHEMOTHERAPEAN AGENTS
PE20060608A1 (es) * 2004-10-13 2006-08-22 Wyeth Corp Analogos de 17-hidroxiwortmanina como inhibidores de pi3k
WO2006132675A2 (en) * 2004-12-20 2006-12-14 University Of South Florida Xiap-targeted prostate cancer therapy
WO2007086943A2 (en) * 2005-09-01 2007-08-02 Beth Israel Deaconess Medical Center Wortmannin conjugates and uses thereof
US20070116736A1 (en) * 2005-11-23 2007-05-24 Argentieri Dennis C Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury
PL1965790T3 (pl) * 2005-12-30 2012-05-31 Arizona Board Of Regents Acting On Behalf Of The Univ Of Arizona Metabolity analogów wortmaniny i sposoby ich stosowania
EP2012794B1 (en) * 2006-04-13 2014-09-17 The Trustees of Columbia University in the City of New York Compositions and intraluminal devices for inhibiting vascular stenosis
JP2013527247A (ja) * 2010-06-04 2013-06-27 オンコシレオン インク． ウォルトマンニンアナログによる併用の癌治療
JP2013527248A (ja) * 2010-06-04 2013-06-27 オンコシレオン インク． ウォルトマンニンアナログによる癌の処置
US11197854B1 (en) 2018-11-14 2021-12-14 National Technology & Engineering Solutions Of Sandia, Llc Inhibitors for targeting flaviviruses
CA3124330A1 (en) 2018-12-21 2020-06-25 Daiichi Sankyo Company, Limited Combination of antibody-drug conjugate and kinase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2302021A (en) * 1996-10-16 1997-01-08 Lilly Co Eli Inhibiting bone loss or resorption

Similar Documents

Publication Publication Date Title
JP2005507880A5 (enExample)
JP2004532209A5 (enExample)
JP2007522220A5 (enExample)
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
JP2005523922A5 (enExample)
EP1191614A3 (en) Luminescence device and metal coordination compound therefor
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
DE602005017157D1 (de) Biologisch wirksame klebeartikel und herstellungsverfahren
EP2228064A3 (en) Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
EA200401615A1 (ru) ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
EA200200876A1 (ru) Алкилированные производные имидазопиридина
JP2007502904A5 (enExample)
EP1106607A3 (en) Uracil compounds and their use
JP2005509503A5 (enExample)
JP2025142197A5 (enExample)
CA2458318A1 (en) Wortmannin analogs and methods of using same
ATE516031T1 (de) Verbindungen gegen krebs
RU2003113145A (ru) Замещенные 5r1, 6r2-1, 3,4-тиадиазин-2, амины и содержащие их фармацевтические композиции в качестве фармакологически активных средств, обладающих антикоагулятным и антиагрегатным действием
NO20070421L (no) Radiosensitiviserende middel
JP2007507467A5 (enExample)
JP2004523567A5 (enExample)
UY26416A1 (es) Compuestos
JP2011518228A5 (enExample)
RU2002111465A (ru) Смесь изомеров 2-моноэтаноламино-5(6)-нитро-1-(тиетанил-3)бензимидазола
JP2004517145A5 (enExample)